DiscoverMedscape InDiscussion: PsoriasisS2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?
S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

Update: 2023-04-25
Share

Description

Dr Steve Feldman speaks with Drs Mehta, Ritchlin, and Fried who share an exciting new roadmap for calming key psoriasis comorbidities.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/986151). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-rich Necrotic Core: Results From a Prospective, Observational Study https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.120.011199

Treating the Skin With Biologics in Patients With Psoriasis Decreases the Incidence of Psoriatic Arthritis https://pubmed.ncbi.nlm.nih.gov/34281904/

The Patient Health Questionnaire-2: Validity of a Two-Item Depression Screener https://pubmed.ncbi.nlm.nih.gov/14583691/

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?

S2 Episode 2: Can Psoriasis Care Limit CVD, PsA, and Depression?